Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial update for MARVEL evaluating a mitochondrial antioxidant therapy to resolve inflammation in Ulcerative Colitis; the study is active but not curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mitochondrial Antioxidant Therapy (MARVEL)

Snippet

Sponsor: University of Edinburgh | Conditions: Ulcerative Colitis Flare | Phase 2 | Status: ACTIVE_NOT_RECRUITING